Enhanced O-GlcNAcylation Mediates Cytoprotection under Proteasome Impairment by Promoting Proteasome Turnover in Cancer Cells

Summary: The proteasome is a therapeutic target in cancer, but resistance to proteasome inhibitors often develops owing to the induction of compensatory pathways. Through a genome-wide siRNA screen combined with RNA sequencing analysis, we identified hexokinase and downstream O-GlcNAcylation as cell...

詳細記述

書誌詳細

主要な著者:	Eiichi Hashimoto, Shota Okuno, Shoshiro Hirayama, Yoshiyuki Arata, Tsuyoshi Goto, Hidetaka Kosako, Jun Hamazaki, Shigeo Murata
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2020-07-01
シリーズ:	iScience
主題:	Biological Sciences Cell Biology Functional Aspects of Cell Biology Cancer
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2589004220304867
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!